Why intermittent fasting science keeps falling short of the hype

Intermittent fasting has built a reputation as an easier route to weight loss than standard calorie-cutting, with claimed benefits stretching to lower cancer risk and sharper cognition. But as new studies keep contradicting each other — one even linked the practice to greater cardiovascular risk — researchers are asking why the evidence remains so shaky.

University of Illinois at Chicago nutrition professor Krista Varady puts it bluntly: “It’s not magic.” The diet’s roots lie in evolutionary biology. “We didn’t evolve in an environment where we ate three meals a day plus two snacks,” says Mark Mattson, the Johns Hopkins neuroscientist whose work helped found the field. Restricting eating windows forces the body to switch from burning sugar to burning fat, triggering autophagy — a cellular clean-up process Mattson’s influential review in the New England Journal of Medicine linked to longer life and lower rates of diabetes and cancer.

That theory holds up neatly in animals: mice kept on restricted schedules stayed lean and healthy into old age even eating identical calories to free-feeding mice, which grew obese and sick. Translating that into people has proved far messier. Human weight loss from fasting regimens runs around 5%, Varady says — “just as effective as any other diet strategy,” but nowhere near the dramatic animal results. Some metabolic markers do improve, including cholesterol, blood pressure and polycystic ovary syndrome symptoms, though more extreme versions, such as alternate-day fasting, can also erode lean muscle. Evidence on cognition and cancer is similarly thin: a major trial built around a fasting-mimicking diet failed in humans because participants never actually reached the metabolic switch seen in mice, although the 5:2 approach has shown promise helping women with metastatic breast cancer tolerate chemotherapy.

The real obstacle: nobody knows what people eat

Part of the gap is biological — a mouse’s metabolism runs so fast that “a 16-hour fast in a rodent is really equivalent to a several-day fast in a human,” says Courtney Peterson of Harvard School of Public Health, and lab mice are genetically near-identical, making them, in Varady’s words, “just a really bad model” for human variability. But the bigger problem, researchers agree, is that human trials depend on participants honestly reporting what they eat — and many don’t. Varady recalls catching a study volunteer scribbling an entire week of meals from memory just before handing it in: “They were just BSing the whole thing.” Only about half of her subjects even return food diaries.

A 2025 equation suggests roughly 30% of people underreport their intake, typically by 400 to 800 calories a day, according to Aberystwyth University researcher Thomas Wilson — “it’s very rare that people overreport,” he notes. When Varady checked self-reported logs against doubly labelled water tests, the gold-standard method for tracking actual energy use, the gap was stark: participants claimed far fewer calories than the objective data showed.

Costly, tightly controlled inpatient trials avoid this problem and have shown stronger results — lower blood sugar and blood pressure, reduced oxidative stress — but tend to be small and brief. Researchers are now testing less invasive alternatives: wearable cameras that photograph meals automatically, chewing-detection necklaces, smart forks and tooth-mounted sensors, alongside more practical blood and urine panels. “Urine and blood analysis is going to give you much more composition information,” Wilson says. His team is now combining several such tools, hoping to get lab-quality data from people living ordinary lives. “I don’t want to be having to ask you to interpret what you ate yesterday,” he says.

Source: BBC News